Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Sigma-2 receptors as a biomarker of proliferation in solid tumours.

Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, Mach RH.

Br J Cancer. 2000 Mar;82(6):1223-32.

2.

Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells.

Al-Nabulsi I, Mach RH, Wang LM, Wallen CA, Keng PC, Sten K, Childers SR, Wheeler KT.

Br J Cancer. 1999 Nov;81(6):925-33.

4.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID:
18037662
5.

Expression of vascular endothelial growth factor receptor Flk-1 in canine mammary tumours.

Restucci B, Borzacchiello G, Maiolino P, Martano M, Paciello O, Papparella S.

J Comp Pathol. 2004 Feb-Apr;130(2-3):99-104.

PMID:
15003465
6.

Sigma 2 receptors as potential biomarkers of proliferation in breast cancer.

Mach RH, Smith CR, al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT.

Cancer Res. 1997 Jan 1;57(1):156-61.

7.

Cyclohexylpiperazine derivative PB28, a sigma2 agonist and sigma1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer.

Azzariti A, Colabufo NA, Berardi F, Porcelli L, Niso M, Simone GM, Perrone R, Paradiso A.

Mol Cancer Ther. 2006 Jul;5(7):1807-16.

8.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
9.
10.

Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.

Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL.

J Pathol. 2008 Feb;214(3):337-46.

PMID:
17985332
11.

Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer.

Hawkin RA, Arends MJ, Ritchie AA, Langdon S, Miller WR.

Breast. 2000 Apr;9(2):96-106.

PMID:
14731708
12.

Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies.

Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M.

Radiother Oncol. 2006 Nov;81(2):122-9. Epub 2006 Sep 7.

PMID:
16956683
13.

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME.

Cancer Res. 2000 Jun 1;60(11):3081-7.

14.

Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.

Imai M, Muraki M, Takamatsu K, Saito H, Seiki M, Takahashi Y.

BMC Cancer. 2008 Nov 4;8:319. doi: 10.1186/1471-2407-8-319.

15.
16.

The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.

Oncogene. 2008 Jan 31;27(6):865-76. Epub 2007 Jul 23.

PMID:
17653090
17.

Correlation between cathepsin D expression and p53 protein nuclear accumulation in oesophageal squamous cell carcinoma.

Ikeguchi M, Sakatani T, Ueta T, Fukuda K, Oka S, Hisamitsu K, Yamaguchi K, Tsujitani S, Kaibara N.

J Clin Pathol. 2002 Feb;55(2):121-6.

18.

Steroid receptors and proliferation in the human breast.

Clarke RB.

Steroids. 2003 Nov;68(10-13):789-94. Review.

PMID:
14667969
20.

Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.

Filippella M, Galland F, Kujas M, Young J, Faggiano A, Lombardi G, Colao A, Meduri G, Chanson P.

Clin Endocrinol (Oxf). 2006 Oct;65(4):536-43.

PMID:
16984249

Supplemental Content

Support Center